Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

21 November, 2024 | Thursday

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

14 July 2023 | Friday | News

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2023 after the market close on Wednesday, August 9th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET.

Image Source | Public Domain

Image Source | Public Domain

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.

A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

Partner Content

Maximize Time for Innovation: Strategies for Reducing Non-Core Tasks in the Lab
09 August, 2024
Extractables in single-use systems used in ADC manufacturing
19 June, 2024
Empower the Next Wave of Pharmaceutical Breakthroughs with Molecule GEN's AI-Driven Innovation
13 February, 2024
Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!
03 December, 2024
Three Ways Chromatography Data System Software Drives the Lab of the Future
23 October, 2024

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2024 Biopharma Boardroom. All Rights Reserved.